PHOENIX and BEVERLY, Mass., July 15, 2021 /PRNewswire/ -- Amidst the darkness of the pandemic, a shining light from the COVID-19 response is the proliferation of better, faster, more accurate — and ...

February 26, 2026 / Tecogen Inc. (NYSE American:TGEN) will release FY 2025 financial results on Wednesday, March 18th. The ...

The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is partnering with a Silicon Valley firm to become one of the first research institutes in the world to employ a new ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

PHOENIX — What is “long COVID” and could you be suffering from it? A new study hopes to define it. Phoenix-based Translational Genomics Research Institute (TGen) needs participants that will measure ...

PHOENIX, Ariz. — April 15, 2014 — The Translational Genomics Research Institute (TGen) recently honored two significant Arizona philanthropists at their annual Founders Dinner for their support of ...

Colleen's Dream Foundation, a Scottsdale-based nonprofit, today announced a $30,000 grant to the Translational Genomics Research Institute (TGen) to research new ways of treating ovarian cancer. The ...

PHOENIX– Phoenix-based Translational Genomics Research Institute announced Monday it had received a grant from the Taiwan Semiconductor Manufacturing Co. to track variants of COVID-19. The grant for ...

PHOENIX, Ariz. -- April 13, 2021 -- Findings of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that increasing expression of a gene known as ...

PHOENIX — The Translational Genomics Research Institute (TGen) is now testing pets of Arizonans who have contracted COVID-19 in order to better track and understand the virus. "Among the more than 120 ...

Since mid-January, the Translational Genomics Research Institute (TGen) has joined the world-wide effort to test for the SARS-CoV-2 virus causing the COVID-19 disease. Acting as Genomic First ...

Phoenix medical-research nonprofit TGen has licensed a blood-biopsy method to test for cancer to a for-profit public company in an effort to expand reach of the technology. Exact Sciences Corp. of ...